Share Name Share Symbol Market Type Share ISIN Share Description
Benchmark Holdings LSE:BMK London Ordinary Share GB00BGHPT808 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 49.50p 48.00p 51.00p 50.25p 49.50p 49.50p 173,044 14:00:11
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 109.4 -22.4 -4.4 - 258.57

Benchmark Holdings Share Discussion Threads

Showing 526 to 550 of 550 messages
Chat Pages: 22  21  20  19  18  17  16  15  14  13  12  11  Older
DateSubjectAuthorDiscuss
20/11/2017
19:13
Yes looking good, needs some buying action or news and we are straight to 60p . Ultimately I’m hoping it becomes a £1 plus
john09
09/11/2017
10:38
Bought into these after yesterday's announcement. Technically looking very strong.
essential
08/11/2017
18:19
Today's news I think is the kind of news a billion pound biotech would put out. Can I see the share price being £2 one day? Yes
john09
08/11/2017
18:11
A move up to 60p looks inevitable in November imho
john09
08/11/2017
15:40
Yes but I assume just like the sea lice treatment they get payed during the field trial
sebass
08/11/2017
15:01
That's the one. They have to carry out field trial before full launch, so 2019 might be correct still.
ilovefrogs
08/11/2017
14:29
Does anyone know which product this is from half year presentation on website. From the product pipeline in the breeding genetics looks like it could be the one below although it was supposed to be launched in 2019? Size of peak sales supposed to be £32m? 2019 32m DP001 Aquaculture Shrimp In-house ●2019 32m DP001 Aquaculture Shrimp In-house ●
sebass
08/11/2017
10:50
My 45.9p last week looks well timed anyway
john09
08/11/2017
10:02
Phow - that's a big 'if' with these guys though, right? Fingers crossed!
ilovefrogs
08/11/2017
08:10
Newsflow definitely improving here. If that translates into revenue then here looks a great buy point.
phowdo
08/11/2017
08:04
Huge news on shrimps
nw99
06/11/2017
08:53
Valuing this stock on earnings makes no sense in my view - the company has been ploughing money into a slew of new products, and building its new Braintree plant. Valuing it on revenues makes more sense - currently around 2.5x. Now the tricky bit - successful Biotech in the development phase can go as high as 10x, but that's not appropriate here, given the different businesses they have. If you believe that the new salmon vaccine and other products will be successful, then 5x sales would seem fair, which takes you to around 90p per share on current revenues, but remember revenues will also be growing strongly. So, good progress this year could result in a 3 digit price again in 12 months time, but we do need to see the progress!
ilovefrogs
06/11/2017
07:54
Good additions to the board stronger and stronger
nw99
04/11/2017
12:39
Have a read of the pipeline products and estimated sales in the half year results and see what you think
john09
04/11/2017
12:27
Price points for fish an absolute fraction of the price you put on keeping a human healthy and I don't think I need to explain why! Can never spend more on a fish than the price to sell it, and realistically, any cost to process/keep a fish healthy needs to be extremely small so that fisheries/manufacturers/retailers can maintain margins.
dan_the_epic
04/11/2017
12:13
Depends if you think there are more fish or more people on the planet I guess lol. I think there are probably more fish on the basis that people are higher in the food chain and well, I've eaten more fish than people so far in my life
john09
04/11/2017
12:03
Yep, but that's the way to value a company like this, surely. It's not the sole pioneer in its field and, unlike a biotech, the end markets here are generally much smaller Might be missing something obvious ?
dan_the_epic
04/11/2017
11:52
You mean the martket cap vs profit? Yes I think that's why I liken it to a biotech. In 2013 it listed at 64p but the share price opened at 75p and was £1.45 within days. Like I said not necessarily one to trade but stick it away I think it'll move nicely
john09
04/11/2017
11:49
Valuation here is still mental though
dan_the_epic
04/11/2017
11:45
Yes I've not bought it to trade but looks like it's bottomed out. Reminds me a bit of a biotech company with plenty of R&D and future promise. Actually I think it'll get taken out judging by the pipeline of products at various stages of development. I think it's a buy and hold til it's taken private.
john09
04/11/2017
09:19
Think where we are now is a decent entry point bought a good few for my SIPP a few weeks ago what will a penny or two matter in the long term. we have had an update on the current trading which will be in line the below taken from the update on 08.09.17, Looks good to me . Overall performance across the Group has been good, with strong growth in sales in the Breeding and Genetics Division, and improved market conditions for the Advanced Animal Nutrition Division in the second half.
wskill
03/11/2017
14:32
Looks like my order filled . I'm in
john09
03/11/2017
10:11
I'm looking to buy some of these. - What are people's entry points out of interest? - What do you see as the potential share price catalysts in 2018?
john09
30/10/2017
12:16
SCSW very bullish on this
nw99
30/10/2017
09:10
Story in the independent today: http://www.msn.com/en-gb/news/world/scottish-salmon-sold-by-a-range-of-supermarkets-in-the-uk-has-sea-lice-up-to-20-times-acceptable-limit/ar-AAucyPt?li=AAmiR2Z&ocid=ientp
bikwik
Chat Pages: 22  21  20  19  18  17  16  15  14  13  12  11  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20171122 05:50:14